Michelle Yanez
Patrimonio netto: 75 287 $ in data 31/05/2026
Patrimonio netto: 75 287 $ in data 31/05/2026
Ms. Michelle Yanez is an Independent Director at Inhibitor Therapeutics, Inc., a Member at Institute of Management Accountants, Inc. and a Member at Sec Professionals Group.
She is on the Board of Directors at Inhibitor Therapeutics, Inc. Ms. Yanez was previously employed as a Chief Financial Officer, Secretary & Treasurer by MIRA Pharmaceuticals, Inc., a Chief Financial Officer, Secretary & Treasurer by Telomir Pharmaceuticals, Inc., and a Director-Financial Reporting by BioDelivery Sciences International, Inc. She received her undergraduate degree from the University of South Florida and an MBA from Rutgers Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2025 | 896.271 ( 0,52% ) | 75 287 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 13/10/2023 |
Institute of Management Accountants, Inc.
Institute of Management Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a association of accountants and financial professionals | Corporate Officer/Principal | - |
Sec Professionals Group | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 16/05/2025 |
| TELOMIR PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 15/05/2025 |
| HEDGEPATH PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 14/05/2023 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Corporate Officer/Principal | 01/04/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Management Accountants, Inc.
Institute of Management Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a association of accountants and financial professionals | Commercial Services |
Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Rutgers Business School
Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sec Professionals Group | Commercial Services |
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale